109 related articles for article (PubMed ID: 1672074)
1. The role of ras gene expression and transforming growth factor alpha production in the etiology and progression of rodent and human breast cancer.
Salomon DS; Ciardiello F; Valverius EM; Kim N
Cancer Treat Res; 1991; 53():107-57. PubMed ID: 1672074
[No Abstract] [Full Text] [Related]
2. Transforming growth factor alpha and mouse models of human breast cancer.
Humphreys RC; Hennighausen L
Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694
[TBL] [Abstract][Full Text] [Related]
3. Mouse models for breast cancer.
Hennighausen L
Oncogene; 2000 Feb; 19(8):966-7. PubMed ID: 10713679
[No Abstract] [Full Text] [Related]
4. The effects of aromatase overexpression on mammary growth and gene expression in the aromatase x transforming growth factor alpha double transgenic mice.
Kirma N; Mandava U; Wuichet K; Tekmal RR
J Steroid Biochem Mol Biol; 2001 Nov; 78(5):419-26. PubMed ID: 11738552
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-alpha and its role in neoplastic progression.
Lee DC; Luetteke NC; Petch LA
Cancer Treat Res; 1992; 63():233-54. PubMed ID: 1363359
[No Abstract] [Full Text] [Related]
6. Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats.
Gould MN
Semin Cancer Biol; 1993 Jun; 4(3):161-9. PubMed ID: 8318692
[TBL] [Abstract][Full Text] [Related]
7. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.
Davies BR; Platt-Higgins AM; Schmidt G; Rudland PS
Am J Pathol; 1999 Jul; 155(1):303-14. PubMed ID: 10393862
[TBL] [Abstract][Full Text] [Related]
8. Role of transforming growth factor-alpha (TGF-alpha) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-alpha and EGF receptor antibodies.
Ahmed SR; Badger B; Wright C; Manni A
J Steroid Biochem Mol Biol; 1991 Jun; 38(6):687-93. PubMed ID: 2064983
[TBL] [Abstract][Full Text] [Related]
9. Induction of a variety of preneoplasias and tumours in the mammary glands of transgenic rats.
Davies BR; Warren JR; Schmidt G; Rudland PS
Biochem Soc Symp; 1998; 63():167-84. PubMed ID: 9513721
[TBL] [Abstract][Full Text] [Related]
10. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
Nørgaard P; Law B; Joseph H; Page DL; Shyr Y; Mays D; Pietenpol JA; Kohl NE; Oliff A; Coffey RJ; Poulsen HS; Moses HL
Clin Cancer Res; 1999 Jan; 5(1):35-42. PubMed ID: 9918200
[TBL] [Abstract][Full Text] [Related]
11. Different gene expression of mouse transforming growth factor alpha between pregnant mammary glands and mammary tumors in C3H/He mice.
Harigaya T; Tsunoda S; Mizuno M; Nagasawa H
Zoolog Sci; 1994 Aug; 11(4):625-7. PubMed ID: 7765502
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered rat models for breast cancer.
Smits BM; Cotroneo MS; Haag JD; Gould MN
Breast Dis; 2007; 28():53-61. PubMed ID: 18057543
[TBL] [Abstract][Full Text] [Related]
13. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
16. Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers.
Dong Y; Asch HL; Medina D; Ip C; Ip M; Guzman R; Asch BB
Int J Cancer; 1999 Jun; 81(6):930-8. PubMed ID: 10362141
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.
Coffey RJ; Meise KS; Matsui Y; Hogan BL; Dempsey PJ; Halter SA
Cancer Res; 1994 Apr; 54(7):1678-83. PubMed ID: 8137281
[TBL] [Abstract][Full Text] [Related]
18. A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer.
Hollern DP; Yuwanita I; Andrechek ER
Oncogene; 2013 Mar; 32(10):1296-304. PubMed ID: 22525269
[TBL] [Abstract][Full Text] [Related]
19. Chromosome alterations in rat mammary tumor progression.
Aldaz CM; Gollahon LS; Chen A
Prog Clin Biol Res; 1992; 376():137-53. PubMed ID: 1528918
[No Abstract] [Full Text] [Related]
20. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
